Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James P Allison

Showing results (151-160 of 206) with videos related to

Pageof 21
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|February 22, 2008
Immunologic and clinical effects of antibody blockade of cytotoxic T lymphocyte-associated antigen 4 in previously vaccinated cancer patientsF Stephen Hodi, Marcus Butler, Darryl A Oble, et al.
Annals of the New York Academy of Sciences|November 13, 2020
Frontiers in cancer immunotherapy-a symposium reportJennifer Cable, Benjamin Greenbaum, Dana Pe'er, et al.
Science Translational Medicine|April 3, 2020
Neoantigen responses, immune correlates, and favorable outcomes after ipilimumab treatment of patients with prostate cancerSumit K Subudhi, Luis Vence, Hao Zhao, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 17, 2008
CTLA-4 blockade enhances polyfunctional NY-ESO-1 specific T cell responses in metastatic melanoma patients with clinical benefitJianda Yuan, Sacha Gnjatic, Hao Li, et al.
The New England Journal of Medicine|March 9, 2012
Immunologic correlates of the abscopal effect in a patient with melanomaMichael A Postow, Margaret K Callahan, Christopher A Barker, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 27, 2003
Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanomaGiao Q Phan, James C Yang, Richard M Sherry, et al.
Nature|February 10, 2012
Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoeditingHirokazu Matsushita, Matthew D Vesely, Daniel C Koboldt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 31, 2019
Characterization and Comparison of GITR Expression in Solid TumorsLuis Vence, Samantha L Bucktrout, Irina Fernandez Curbelo, et al.
Cancer Immunology Research|January 18, 2018
Robust Antitumor Responses Result from Local Chemotherapy and CTLA-4 BlockadeCharlotte E Ariyan, Mary Sue Brady, Robert H Siegelbaum, et al.
Cancer Research|November 9, 2016
Suppression of Type I IFN Signaling in Tumors Mediates Resistance to Anti-PD-1 Treatment That Can Be Overcome by RadiotherapyXiaohong Wang, Jonathan E Schoenhals, Ailin Li, et al.
Pageof 21

Showing results (151-160 of 206) with videos related to

Sort By:
Pageof 21
Proceedings of the National Academy of Sciences of the United States of America|February 22, 2008
Immunologic and clinical effects of antibody blockade of cytotoxic T lymphocyte-associated antigen 4 in previously vaccinated cancer patientsF Stephen Hodi, Marcus Butler, Darryl A Oble, et al.
Annals of the New York Academy of Sciences|November 13, 2020
Frontiers in cancer immunotherapy-a symposium reportJennifer Cable, Benjamin Greenbaum, Dana Pe'er, et al.
Science Translational Medicine|April 3, 2020
Neoantigen responses, immune correlates, and favorable outcomes after ipilimumab treatment of patients with prostate cancerSumit K Subudhi, Luis Vence, Hao Zhao, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 17, 2008
CTLA-4 blockade enhances polyfunctional NY-ESO-1 specific T cell responses in metastatic melanoma patients with clinical benefitJianda Yuan, Sacha Gnjatic, Hao Li, et al.
The New England Journal of Medicine|March 9, 2012
Immunologic correlates of the abscopal effect in a patient with melanomaMichael A Postow, Margaret K Callahan, Christopher A Barker, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 27, 2003
Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanomaGiao Q Phan, James C Yang, Richard M Sherry, et al.
Nature|February 10, 2012
Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoeditingHirokazu Matsushita, Matthew D Vesely, Daniel C Koboldt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 31, 2019
Characterization and Comparison of GITR Expression in Solid TumorsLuis Vence, Samantha L Bucktrout, Irina Fernandez Curbelo, et al.
Cancer Immunology Research|January 18, 2018
Robust Antitumor Responses Result from Local Chemotherapy and CTLA-4 BlockadeCharlotte E Ariyan, Mary Sue Brady, Robert H Siegelbaum, et al.
Cancer Research|November 9, 2016
Suppression of Type I IFN Signaling in Tumors Mediates Resistance to Anti-PD-1 Treatment That Can Be Overcome by RadiotherapyXiaohong Wang, Jonathan E Schoenhals, Ailin Li, et al.
Pageof 21